AMEX:SLS - SLS International Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
Previous Close$0.0008
Today's RangeN/A
52-Week RangeN/A
VolumeN/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
SLS international is a language services company which offers translations globally. The Company offers a range of services, including multilingual translations into all Spanish variants, localization, adaptation and content editing. It uses the mother-tongue linguists in order to meet the demanding standards. Its professional team includes translators, terminologists, linguistic engineers, IT experts, technical editors and graphic designers. The Company’s production offices and management departments are located in Argentina, Spain, Uruguay and Panama. The Company offers translations within a range of fields such as legal, financial, business, economy, and health sciences, marketing, advertising and technical. It translates and adapts all of the customer’s software products, such as resource files, online help, printed documentation, including compilation and testing of various components.

Receive SLS News and Ratings via Email

Sign-up to receive the latest news and ratings for SLS and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorN/A
CUSIPN/A
Phone+1-417-8834549

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable

SLS International (AMEX:SLS) Frequently Asked Questions

What is SLS International's stock symbol?

SLS International trades on the AMEX under the ticker symbol "SLS."

How were SLS International's earnings last quarter?

SLS International Inc (AMEX:SLS) announced its quarterly earnings results on Thursday, November, 15th. The biotechnology company reported ($0.53) earnings per share (EPS) for the quarter, missing the Zacks' consensus estimate of ($0.36) by $0.17. View SLS International's Earnings History.

What price target have analysts set for SLS?

4 brokers have issued 12 month price objectives for SLS International's shares. Their predictions range from $4.00 to $13.00. On average, they expect SLS International's share price to reach $7.3333 in the next twelve months. View Analyst Price Targets for SLS International.

What is the consensus analysts' recommendation for SLS International?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for SLS International in the last year. There are currently 1 hold rating and 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for SLS International.

What are Wall Street analysts saying about SLS International stock?

Here are some recent quotes from research analysts about SLS International stock:
  • 1. Maxim Group analysts commented, "Sellas reported FYE18 with operating expenses of $31.1M which included an impairment charge of $9.6M. Net loss was ($27.7M) and loss attributable to common stockholders was ($41.3M). Sellas ended the year with $5.3M in cash. A warrant exchange in March 2019 could bring in $4.18M. The company still needs to raise capital to support the planned P3 study of galinpepimut-S (GPS) and is currently exploring strategic options, including around nelipepimut-S (NPS) in triple negative breast cancer. We believe the fundamentals remain intact and our positive views around GPS and NPS remain unchanged. That said, we are downgrading to and removing our price target while Sellas addresses its capital needs." (3/22/2019)
  • 2. According to Zacks Investment Research, "SELLAS Life Sciences Group is a development-stage biopharmaceutical company. It focused on novel cancer immunotherapeutics for cancer indications. The company's product candidate, galinpepimut-S, is licensed from Memorial Sloan Kettering Cancer Center and targets the Wilms Tumor 1 protein, which is present in an array of tumor types. SELLAS Life Sciences Group Inc., formerly known as Galena Biopharma Inc., is based in NEW YORK, United States. " (1/16/2019)

Has SLS International been receiving favorable news coverage?

News articles about SLS stock have trended somewhat negative recently, according to InfoTrie. InfoTrie ranks the sentiment of media coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. SLS International earned a coverage optimism score of -1.4 on InfoTrie's scale. They also assigned news headlines about the biotechnology company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the company's share price in the immediate future.

What other stocks do shareholders of SLS International own?

Who are SLS International's key executives?

SLS International's management team includes the folowing people:
  • Angelos M. Stergiou M.D., President, Chief Executive Officer, Director
  • Aleksey N. Krylov, Interim Chief Financial Officer, Treasurer
  • Nicholas J. Sarlis M.D. Ph.D., Chief Medical Officer, Senior Vice President
  • Gregory M. Torre Ph.D. J.D., Chief Regulatory Officer, Senior Vice President
  • John Thomas Burns, Vice President - Finance, Corporate Controller
  • Fabio Lopez, Director
  • David A. Scheinberg, Director
  • Stephen F. Ghiglieri, Independent Director (Age 55)
  • Robert L. Van Nostrand, Independent Director
  • John Varian, Independent Director

How do I buy shares of SLS International?

Shares of SLS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is SLS International's official website?

The official website for SLS International is http://www.sls-international.com/.

How can I contact SLS International?

SLS International's mailing address is 3119 S Scenic Ave, SPRINGFIELD, MO 65807-3926, United States. The biotechnology company can be reached via phone at +1-417-8834549 or via email at [email protected]


MarketBeat Community Rating for SLS International (AMEX SLS)

Community Ranking:  3.5 out of 5 (star star star half star)
Outperform Votes:  387 (Vote Outperform)
Underperform Votes:  168 (Vote Underperform)
Total Votes:  555
MarketBeat's community ratings are surveys of what our community members think about SLS International and other stocks. Vote "Outperform" if you believe SLS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SLS will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 3/23/2019 by MarketBeat.com Staff

Featured Article: Reverse Stock Split

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel